Section 313.132 | Screening for presence of buprenorphine, naltrexone, and methadone.
Effective:
September 29, 2017
Latest Legislation:
House Bill 49 - 132nd General Assembly
If an autopsy includes a toxicological analysis, the coroner, deputy coroner, or pathologist shall screen for the presence of buprenorphine, naltrexone, and methadone.
Available Versions of this Section
- September 29, 2017 – Enacted by House Bill 49 - 132nd General Assembly [ View September 29, 2017 Version ]